Previous Article | Next Article ![]()
Infection and Immunity, June 2007, p. 3197-3201, Vol. 75, No. 6
0019-9567/07/$08.00+0 doi:10.1128/IAI.01611-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Pauline T. Lukey,2
Jacqueline M. Cliff,1* and
Hazel M. Dockrell1
Department of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom,1 GlaxoSmithKline R&D, Stevenage, United Kingdom2
Received 5 October 2006/ Returned for modification 18 December 2006/ Accepted 14 March 2007
Three commonly used Mycobacterium bovis BCG vaccine strains elicited different magnitudes of T-cell activation and gamma interferon production in vitro in healthy BCG-vaccinated individuals. Glaxo 1077 exhibited the greatest stimulatory capacity, followed by Pasteur 1173 and then Danish 1331. These differences may affect in vitro stimulation and vaccination-induced immunogenicity.
Published ahead of print on 26 March 2007.
Present address: Institute of Cell and Molecular Science, Queen Mary's School of Medicine and Dentistry, London, United Kingdom.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»